Research graph
References from The biology of Epstein–Barr virus in post‐transplant lymphoproliferative disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Determination of the role for CD21 during Epstein–Barr virus infection of B lymphoblastoid cells.
10.1128/jvi.68.8.4716-4726.1994 · 1994 · External reference
Concatameric replication of Epstein–Barr virus: structure of the termini in virus‐producer and newly transformed cell lines.
10.1128/jvi.64.11.5295-5300.1990 · 1990 · External reference
Unresolved reference
1996 · External reference
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein–Barr virus DNA.
10.1128/jvi.69.1.231-238.1995 · 1995 · External reference
10.1038/313812a0
10.1038/313812a0 · External reference
10.1128/jvi.68.6.4067-4071.1994
10.1128/jvi.68.6.4067-4071.1994 · External reference
10.1073/pnas.91.16.7568
10.1073/pnas.91.16.7568 · External reference
10.1126/science.8016657
10.1126/science.8016657 · External reference
10.1126/science.7725102
10.1126/science.7725102 · External reference
10.1073/pnas.94.4.1447
10.1073/pnas.94.4.1447 · External reference
10.1016/0092-8674(85)90256-9
10.1016/0092-8674(85)90256-9 · External reference
Detection and characterization of Epstein–Barr virus in clinical specimens.
1994 · External reference
10.1073/pnas.90.18.8479
10.1073/pnas.90.18.8479 · External reference
10.1126/science.2161559
10.1126/science.2161559 · External reference
10.1146/annurev.iy.11.040193.001121
10.1146/annurev.iy.11.040193.001121 · External reference
Unresolved reference
1996 · External reference
10.1002/ijc.2910170105
10.1002/ijc.2910170105 · External reference
10.1093/infdis/168.2.345
10.1093/infdis/168.2.345 · External reference
Identification of the site of Epstein–Barr virus persistence in vivo as a resting B cell.
10.1128/jvi.71.7.4882-4891.1997 · 1997 · External reference
Epstein–Barr virus latency in blood mononuclear cells–analysis of viral gene transcription during primary infection and in the carrier state.
10.1128/jvi.68.11.7374-7385.1994 · 1994 · External reference
Expression of Epstein–Barr virus BamHI‐A rightward transcripts in latently infected B cells from peripheral blood.
1999 · External reference
Methylation of Epstein–Barr virus genome in normal lymphocytes.
10.1182/blood.v90.11.4480 · 1997 · External reference
X‐Linked agammaglobulinemia patients are not infected with Epstein–Barr virus: implications for the biology of the virus.
10.1128/jvi.73.2.1555-1564.1999 · 1999 · External reference
10.1073/pnas.85.22.8693
10.1073/pnas.85.22.8693 · External reference
10.1002/ijc.2910130311
10.1002/ijc.2910130311 · External reference
Localization of Epstein–Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development.
10.1084/jem.176.1.169 · 1992 · External reference
10.1084/jem.176.1.157
10.1084/jem.176.1.157 · External reference
10.1038/375685a0
10.1038/375685a0 · External reference
10.1111/j.1365-2559.1992.tb01007.x
10.1111/j.1365-2559.1992.tb01007.x · External reference
Polymorphic diffuse B‐cell hyperplasias and lymphomas in renal transplant recipients.
1981 · External reference
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post transplantation lymphoproliferative disorders.
10.1182/blood.v85.2.552.552 · 1995 · External reference
Clonal analysis of transplant‐associated lymphoproliferations based on the structure of the genomic termini of the Epstein–Barr virus.
10.1182/blood.v72.1.349.349 · 1988 · External reference
10.1093/infdis/160.4.589
10.1093/infdis/160.4.589 · External reference
The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporin A–prednisone immunosuppression.
1988 · External reference
BCL‐6 gene mutations in posttransplant lymphoproliferative disorders predict response to therapy and clinical outcome.
10.1182/blood.v92.7.2294 · 1998 · External reference
10.1056/nejm198910193211604
10.1056/nejm198910193211604 · External reference
10.1016/s0889-8588(05)70473-1
10.1016/s0889-8588(05)70473-1 · External reference
Epstein–Barr virus lymphoproliferation after bone marrow transplantation.
10.1182/blood.v72.2.520.520 · 1988 · External reference
Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.
10.1182/blood.v71.5.1234.1234 · 1988 · External reference
Post‐transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
1995 · External reference
10.1200/jco.1998.16.6.2052
10.1200/jco.1998.16.6.2052 · External reference
10.1097/00007890-199601150-00015
10.1097/00007890-199601150-00015 · External reference
10.1093/oxfordjournals.annonc.a010570
10.1093/oxfordjournals.annonc.a010570 · External reference
Post‐transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine‐based immunosuppression.
1991 · External reference
10.1093/infdis/152.5.876
10.1093/infdis/152.5.876 · External reference
10.1016/s0140-6736(84)90994-2
10.1016/s0140-6736(84)90994-2 · External reference
10.1016/s0140-6736(84)91293-5
10.1016/s0140-6736(84)91293-5 · External reference
10.1056/nejm199012203232502
10.1056/nejm199012203232502 · External reference
Epstein–Barr virus lymphoproliferation after bone marrow transplantation.
10.1182/blood.v72.2.520.520 · 1988 · External reference
T‐cell‐depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.
10.1182/blood.v76.1.235.235 · 1990 · External reference
10.1056/nejm199404283301703
10.1056/nejm199404283301703 · External reference
Low risk of Epstein–Barr virus (EBV)‐associated post‐transplant lymphoproliferative disease (PTLD) in patients receiving elutriated allogeneic marrow transplants may reflect depletion of EBV infected lymphocytes from the graft.
1995 · External reference
Risks of developing Epstein–Barr virus‐related lymphoproliferative disorders after T‐cell‐depleted marrow transplants. CAMPATH Users.
10.1182/blood.v91.8.3079.3079_3079_3083 · 1998 · External reference
Direct correlation between the load of Epstein–Barr virus‐infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.
10.1182/blood.v83.9.2715.2715 · 1994 · External reference
Infusion of cytotoxic T cells for the prevention and treatment of Epstein–Barr virus‐induced lymphoma in allogeneic transplant recipients.
10.1182/blood.v92.5.1549.417k32_1549_1555 · 1998 · External reference
Semiquantitative Epstein–Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease.
10.1182/blood.v92.10.3977 · 1998 · External reference
EBV quantitation in serum is highly correlated with development and regression of post‐transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients.
1999 · External reference
10.1056/nejm198204153061506
10.1056/nejm198204153061506 · External reference
Antiviral prophylaxis and the Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder.
10.1111/j.1399-0012.1995.tb00297.x · 1995 · External reference
10.1002/ijc.2910430115
10.1002/ijc.2910430115 · External reference
10.1097/00007890-199509270-00005
10.1097/00007890-199509270-00005 · External reference
10.1056/nejm198909213211203
10.1056/nejm198909213211203 · External reference
Epstein–Barr virus lymphoproliferation after bone marrow transplantation.
10.1182/blood.v72.2.520.520 · 1988 · External reference
10.1056/nejm199105233242102
10.1056/nejm199105233242102 · External reference
Anti‐B‐cell monoclonal antibody treatment of severe post‐transplant B‐lymphoproliferative disorder: prognostic factors and long‐term outcome.
10.1182/blood.v92.9.3137 · 1998 · External reference
10.3109/10428199709058335
10.3109/10428199709058335 · External reference
10.1016/s0952-7915(96)80036-7
10.1016/s0952-7915(96)80036-7 · External reference
Unresolved reference
External reference
Epstein–Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
1994 · External reference
Epstein–Barr virus‐latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome‐related non‐Hodgkins lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
1993 · External reference
10.1016/s0046-8177(96)90401-3
10.1016/s0046-8177(96)90401-3 · External reference
10.1016/s0065-230x(08)60319-x
10.1016/s0065-230x(08)60319-x · External reference
Kaposis sarcoma‐associated herpesvirus in non‐AIDS related lymphomas occurring in body cavities.
1996 · External reference
10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t
10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t · External reference
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein–Barr virus in formalin‐fixed paraffin‐embedded carcinoma specimens.
1991 · External reference
Association of Epstein–Barr virus with leiomyosarcomas in young people with AIDS.
10.1056/nejm199501053320103 · 1995 · External reference
